KPJ Healthcare Bhd has signed a memorandum of understanding (MoU) with Novo Nordisk Malaysia to develop a structured, hospital-based programme aimed at improving multidisciplinary care for patients living with obesity and related metabolic conditions.
The collaboration will underpin the KPJ Metabolic & Weight Management Programme, designed to deliver specialist-led, coordinated care within a regulated healthcare setting, addressing rising demand for safer, medically supervised treatment pathways.
The initiative comes amid growing health concerns nationwide, with Health Ministry data indicating that one in two Malaysian adults are overweight or obese, while 15.6% live with diabetes, many undiagnosed. Obesity is also estimated to cost the country over RM64 billion annually.
Under the partnership, patients will receive comprehensive care spanning specialist consultations, dietetic support, lifestyle guidance and clinically appropriate therapies.
The programme will integrate multiple disciplines including endocrinology, internal medicine, bariatric surgery, psychology, physiotherapy and pharmacy into a single structured pathway.
The first phase will be rolled out across 10 KPJ hospitals, including facilities in Ipoh, Johor, Penang, Kuching and Klang Valley, with further expansion planned over the next 12 months. Patients will be onboarded via health screenings and in-hospital referrals, with care programmes typically lasting up to six months.
KPJ Healthcare President and Managing Director Chin Keat Chyuan said the collaboration strengthens integrated, long-term care for a complex chronic condition.
“Obesity is closely linked to a wider spectrum of non-communicable diseases and requires coordinated management. This programme brings together clinical expertise and allied health support within a consistent, outcome-driven model,” he said.
Chin added that beyond patient care, the partnership will also focus on clinical education and responsible communication, including the appropriate use of GLP-1-based therapies, as well as broader public awareness of obesity as a treatable chronic disease.
